2024-11-16 07:32:49
Sirnaomics Dosed the First Patient in Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Treatment
Corporate/ 2023-07-24
Sirnaomics Dosed the First Patient in Ph...

HONG KONG,Germantown,Md. and Suzhou,China,June 2,2023-- SirnaomicsLtd.(the "Company"; together with its subsidiaries,the "Gro...

EVERSANA Forms Strategic Alliance with China Resource Pharmaceutical Commercial Group to Bring New Novel Treatments to Patients Globally
Health/ 2023-07-22
EVERSANA Forms Strategic Alliance with C...

BEIJING,June 2,2023-- EVERSANA®,a leading provider of commercialization services to the global life sciences industry,today announced th...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release